Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

421 ARTÍCULOS , VIENDO DEL 46 AL 60

Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia

Adelufosi AO, Abayomi O, Ojo TM.

Cochrane Database Syst Rev. 2015 Apr 13;2015(4):CD010501. doi: 10.1002/14651858.CD010501.pub2.

Low dose of clonazepam is effective in the treatment of painless legs and moving toes syndrome: a case report

Kawajiri S, Noda K, Ikeda A, Koinuma T, Tomizawa Y, Hattori N, Okuma Y.

Case Rep Neurol. 2015 Mar 21;7(1):59-62. doi: 10.1159/000380942. eCollection 2015 Jan-Apr.

Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial

Kefalopoulou Z, Zrinzo L, Jahanshahi M, Candelario J, Milabo C, Beigi M, Akram H, Hyam J, Clayton J, Kass-Iliyya L, Silverdale M, Evans J, Limousin P, Hariz M, Joyce E, Foltynie T.

Lancet Neurol. 2015 Jun;14(6):595-605. doi: 10.1016/S1474-4422(15)00008-3. Epub 2015 Apr 14.

Comprehensive neuromechanical assessment in stroke patients: reliability and responsiveness of a protocol to measure neural and non-neural wrist properties

van der Krogt H, Klomp A, de Groot JH, de Vlugt E, van der Helm FC, Meskers CG, Arendzen JH.

J Neuroeng Rehabil. 2015 Mar 13;12:28. doi: 10.1186/s12984-015-0021-9.

Phenotype-specific diagnosis of functional (psychogenic) movement disorders

Espay AJ, Lang AE.

Curr Neurol Neurosci Rep. 2015 Jun;15(6):32. doi: 10.1007/s11910-015-0556-y.

A novel tau mutation, p.K317N, causes globular glial tauopathy

Tacik P, DeTure M, Lin WL, Sanchez Contreras M, Wojtas A, Hinkle KM, Fujioka S, Baker MC, Walton RL, Carlomagno Y, Brown PH, Strongosky AJ, Kouri N, Murray ME, Petrucelli L, Josephs KA, Rademakers R, Ross OA, Wszolek ZK, Dickson DW.

Acta Neuropathol. 2015 Aug;130(2):199-214. doi: 10.1007/s00401-015-1425-0. Epub 2015 Apr 22.

Genetics and molecular biology of brain calcification

Deng H, Zheng W, Jankovic J.

Ageing Res Rev. 2015 Jul;22:20-38. doi: 10.1016/j.arr.2015.04.004. Epub 2015 Apr 20.

Medically unexplained neurologic symptoms: a primer for physicians who make the initial encounter

Evens A, Vendetta L, Krebs K, Herath P.

Am J Med. 2015 Oct;128(10):1059-64. doi: 10.1016/j.amjmed.2015.03.030. Epub 2015 Apr 22.

Neurodegeneration in the elderly - When the blood type matters: An overview of the McLeod syndrome with focus on hematological features

Frey BM, Gassner C, Jung HH.

Transfus Apher Sci. 2015 Jun;52(3):277-84. doi: 10.1016/j.transci.2015.04.007. Epub 2015 Apr 14.

Movement disorders in systemic lupus erythematosus and antiphospholipid syndrome--a video presentation

Ramcharan K, Abdool K, Persad N, Dyaanand H.

BMJ Case Rep. 2015 May 7;2015:bcr2014209201. doi: 10.1136/bcr-2014-209201.

[Drug use and driving]

Lemaire-Hurtel AS, Goullé JP, Alvarez JC, Mura P, Verstraete AG.

Presse Med. 2015 Oct;44(10):1055-63. doi: 10.1016/j.lpm.2015.03.007. Epub 2015 May 5.

Assessment and treatment of insomnia in adult patients with alcohol use disorders

Brower KJ.

Alcohol. 2015 Jun;49(4):417-27. doi: 10.1016/j.alcohol.2014.12.003. Epub 2015 Jan 7.

Neuroelectronics and Biooptics: Closed-Loop Technologies in Neurological Disorders

Krook-Magnuson E, Gelinas JN, Soltesz I, Buzsáki G.

JAMA Neurol. 2015 Jul;72(7):823-9. doi: 10.1001/jamaneurol.2015.0608.

The neuronal ceroid lipofuscinoses program: A translational research experience in Argentina

Kohan R, Pesaola F, Guelbert N, Pons P, Oller-Ramírez AM, Rautenberg G, Becerra A, Sims K, Xin W, Cismondi IA, Noher de Halac I.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2301-11. doi: 10.1016/j.bbadis.2015.05.003. Epub 2015 May 11.

Drug-induced movement disorders

Zádori D, Veres G, Szalárdy L, Klivényi P, Vécsei L.

Expert Opin Drug Saf. 2015 Jun;14(6):877-90. doi: 10.1517/14740338.2015.1032244.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias